Biopreservation Market Size & Growth Forecast 2026–2035, By Segments (Application, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Biopreservation Market size was valued at USD 4.19 Billion in 2025 and is projected to grow at a 27.4% CAGR from 2026 to 2035, crossing USD 47.2 Billion by 2035. The industry revenue for 2026 is estimated at USD 5.24 billion.
Get more details on this report
Request Free Sample ReportBiopreservation Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 47.70% market share in 2025, supported by advanced biobanking infrastructure, widespread clinical research, established cold-chain systems, and strong demand from pharmaceutical and healthcare laboratories.
- Asia Pacific is projected to grow at a 30.14% CAGR, fueled by expanding life sciences research, rising regenerative medicine investments, growing biobanking activity, and broader adoption of advanced preservation workflows.
Segment Momentum
- Equipment led the biopreservation market with a 75.6% share in 2025 because reliable storage and temperature-control systems are essential for preserving biological materials across laboratories, repositories, and clinical environments.
- Regenerative medicine is expanding fastest because preserving the viability and functional integrity of sensitive cells and tissues has become increasingly important as advanced biologic and precision treatment workflows continue to grow.
Market Expansion Drivers
- Expanding hospital and laboratory usage alongside cell and gene therapy demand.
- Rising government and private funding accelerating biologics and vaccine manufacturing.
- AI-driven predictive models and automated cryopreservation improving sample integrity.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Prominent players in the biopreservation market include Thermo Fisher Scientific Inc. (United States), Azenta, Inc. (United States), BioLife Solutions, Inc. (United States), Panasonic Holdings Corporation (Japan), MVE Biological Solutions (United States), Stirling Ultracold (United States), X-Therma Inc. (United States), LabVantage Solutions, Inc. (United States).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
Broader use of advanced diagnostics, biobanking, and specimen management in hospitals and research laboratories is increasing day-to-day reliance on controlled storage media, freezers, thawing systems, and transport solutions, driving demand for the biopreservation market. This effect becomes more pronounced as cell and gene therapy pipelines move from research settings into clinical workflows, where living cells, tissues, and patient-derived materials must retain viability from collection through processing and administration. Procurement decisions are increasingly tied to preservation performance because sample loss, contamination, or viability decline can disrupt treatment schedules, invalidate laboratory work, and raise operating costs, driving market development around higher-reliability biopreservation systems.
Rising government and private funding accelerating biologics and vaccine manufacturing
As public agencies, pharmaceutical companies, and investors channel more capital into biologics and vaccine production, manufacturers expand upstream and downstream capacity that depends on stable preservation of cell lines, microbial strains, bulk intermediates, and reference materials. In the biopreservation market, this funding translates into purchases of storage infrastructure, preservation media, and cold-chain handling technologies that support process consistency from R&D through commercial manufacturing. The practical impact is strongest in scale-up environments, where funded facilities standardize preservation protocols to reduce batch variability, protect valuable biological assets, and maintain regulatory readiness, contributing to market size growth through recurring operational use rather than one-time installation alone.
AI-driven predictive models and automated cryopreservation improving sample integrity
AI-based monitoring and automated cryopreservation are changing how operators manage temperature profiles, freezing rates, and handling conditions, reducing the manual variability that often compromises high-value biological samples. In the biopreservation market, predictive models help laboratories and production teams anticipate viability loss or storage deviations before they damage cell-based materials, while automation makes preservation workflows more reproducible at larger volumes. This is influencing market adoption of integrated systems that combine software, sensors, and controlled-rate freezing because buyers are prioritizing measurable sample integrity, traceability, and workflow standardization when preserving sensitive therapeutic cells and research specimens.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising demand for biopreservation in cell and tissue storage | 10.00% | Short term (≤ 2 yrs) | North America, Europe (spillover: Asia Pacific) | High | Fast |
| Expansion of biobanking and regenerative medicine applications | 9.00% | Medium term (2–5 yrs) | Europe, North America (spillover: Asia Pacific) | Medium | Moderate |
| Technological advancements in cryopreservation solutions | 8.40% | Long term (5+ yrs) | North America, Europe (spillover: Asia Pacific) | Medium | Slow |
| Expanding hospital and laboratory usage alongside cell and gene therapy demand | 2.60% | High | North America, Europe | High | Near Term |
| Rising government and private funding accelerating biologics and vaccine manufacturing | 2.10% | High | North America, Asia Pacific | High | Mid Term |
| AI-driven predictive models and automated cryopreservation improving sample integrity | 1.70% | Moderate | Europe, Asia Pacific | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the leading biopreservation market position in 2025, accounting for a 47.70% share, bolstered by its established biobanking infrastructure, broad use of advanced cold chain and storage systems, and high concentration of cell therapy, tissue engineering, and clinical research activity. The region’s leadership is strengthened by routine preservation requirements across pharmaceutical development, academic research, and hospital-based laboratories, where sample integrity, regulatory compliance, and long-term storage reliability directly shape purchasing and replacement cycles for preservation media, equipment, and monitoring systems.
Asia Pacific is projected to expand at a 30.14% CAGR over the forecast period, with growth in the biopreservation market being fueled by the rapid buildout of life sciences research capacity, rising investment in regenerative medicine, and expanding biobanking activity across emerging healthcare and research ecosystems. Adoption is accelerating as more laboratories, research centers, and healthcare institutions move from basic storage practices toward higher-specification preservation workflows, creating stronger demand for modern storage equipment, cryopreservation systems, and associated consumables in day-to-day sample handling and long-term biological material management.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Quality-Centric Storage SystemsGermany prioritizes highly regulated biobanking operations and standardized preservation protocols for clinical and pharmaceutical applications. Demand in Germany is supported by research collaborations and the need for reliable sample integrity management across academic and industrial life sciences programs.
France 🇫🇷
Clinical Sample StewardshipFrance is emphasizing secure storage and management of clinical specimens to support biomedical research and personalized medicine initiatives. The biopreservation market in France benefits from growing integration between hospitals, research institutions, and public health biobanking networks.
Italy 🇮🇹
Research Network ExpansionItaly is gradually expanding biopreservation infrastructure to improve access to high-quality biological samples for research and diagnostics. Italian institutions are prioritizing preservation technologies that enhance sample viability and facilitate collaborative research projects across multiple healthcare centers.
Japan 🇯🇵
Regenerative Medicine SupportJapan's focus on regenerative medicine and stem cell research is encouraging wider adoption of advanced biopreservation solutions. Healthcare providers and research organizations in Japan are emphasizing precise cryogenic storage and traceability systems to manage valuable biological samples.
South Korea 🇰🇷
Cell Therapy InfrastructureSouth Korea is strengthening biopreservation capabilities to support its expanding cell therapy and biopharmaceutical sectors. Investments in biobanks and specialized storage facilities are increasing as South Korean companies seek dependable preservation technologies for research and commercial manufacturing activities.
United States 🇺🇸
Advanced Biobanking HubThe U.S. biopreservation market is driven by expanding cell and gene therapy pipelines and increasing demand for long-term storage of biological materials. U.S. healthcare and research institutions are investing in automated cold-chain infrastructure and validated preservation technologies to support clinical and translational research activities.
Segment Leadership and Growth Trends
Biopreservation Market Share (%), Application, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportBio-banking held the strongest position in the biopreservation market in 2025, accounting for a 67.82% share. Its dominance is sustained by the routine need to preserve large volumes of biological samples under controlled conditions for research, clinical reference, and long-term storage. This creates consistent demand for established preservation workflows, making bio-banking the most entrenched application area within the biopreservation market.
Regenerative Medicine is the fastest-growing application in the biopreservation market as cell-based and tissue-focused therapeutic work depends heavily on maintaining viability and functional integrity during storage and handling. Growth is being reinforced through the increasing practical need for preservation solutions that can support sensitive biological materials used in advanced treatment development. Compared with more established applications, regenerative medicine is gaining momentum because its use requirements are expanding alongside the broader adoption of precision biologic workflows.
Product Segment Analysis: Equipment (Largest Segment) vs Media (Fastest-Growing Segment)
Equipment represented the largest product segment in the biopreservation market in 2025, with a 75.6% share. This leadership reflects the central role of storage and temperature-control infrastructure in preserving biological materials reliably across laboratories, repositories, and clinical environments. Because biopreservation depends on durable, validated physical systems for sample integrity, equipment remains the core spending area in the market.
Media is the fastest-growing product segment in the biopreservation market, driven by the need for preservation environments tailored to the biological sensitivity of cells, tissues, and related materials. As end-use applications become more specialized, demand is rising for media that can better support viability and recovery after storage. Relative to equipment, which is often installed as foundational infrastructure, media is gaining faster momentum through recurring use tied directly to evolving preservation protocols.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Application | Regenerative Medicine, Bio-banking, Drug Discovery | Bio-banking | Regenerative Medicine |
| Product | Equipment, Media, Laboratory Information Management System (LIMS) | Equipment | Media |
Competitive Landscape and Market Positioning
1. Thermo Fisher Scientific Inc. (United States)
2. Azenta Inc. (United States)
3. BioLife Solutions Inc. (United States)
4. Panasonic Holdings Corporation (Japan)
5. MVE Biological Solutions (United States)
6. Stirling Ultracold (United States)
7. X-Therma Inc. (United States)
8. LabVantage Solutions Inc. (United States)
In the biopreservation market, advancements are strengthening long-term biological sample stability and storage reliability. Improved cryopreservation techniques are enhancing cell and tissue viability outcomes. The biopreservation market is also seeing expansion in regenerative and clinical research applications. Continuous innovation is improving preservation efficiency across temperature-controlled systems.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| DHL Group | Mar-25 | DHL Group acquired CRYOPDP, expanding its life-science logistics network with coverage across 15 countries and handling approximately 600,000 annual ultra-cold shipments. The transaction strengthens DHL’s controlled-temperature logistics infrastructure, enhancing cold-chain distribution capacity critical for biopreservation and biologics supply chains. |
| Azenta US, Inc. | Jan-25 | Azenta secured a contract with UK Biocentre to deploy BioArc Ultra automation systems, significantly expanding sample storage and processing capacity by approximately 16 million samples for the Our Future Health initiative. The development strengthens large-scale biobanking infrastructure and enhances automated biopreservation capabilities for population-scale biomedical research. |
| FDA | Dec-24 | The FDA approved Symvess, the first acellular tissue-engineered vessel for extremity trauma, marking a regulatory milestone for preserved biological implants. The approval supports the commercialization of advanced preserved tissue-based medical products, reinforcing the role of biopreservation technologies in regenerative medicine and clinical trauma applications. |
| Teknova | Mar-25 | Teknova and Pluristyx introduced PluriFreeze™, an integrated cryopreservation system designed to improve cell-therapy viability and reduce development timelines. The solution strengthens biopreservation workflows by enhancing cell stability during storage and transport, supporting more efficient scaling of advanced cell-therapy manufacturing and distribution processes. |
| Merck | 2024 | Merck invested over USD 321.7 million in a new bioprocessing production center in Daejeon, South Korea, marking its largest Life Science investment in the Asia-Pacific region. The facility expands bioproduction and related infrastructure capacity while reinforcing regional supply chain resilience for bioprocessing and preservation-enabled life science applications. |
| Thermo Fisher Scientific | 2024 | Thermo Fisher Scientific launched a new line of ultra-low temperature (ULT) freezers, the TSX Universal Series, designed to improve performance, energy efficiency, and workflow integration in laboratory environments. The systems enhance cold storage reliability and operational efficiency, supporting improved preservation conditions for biological samples and research materials. |
| Avantor | 2023 | Avantor entered into a partnership with Tobin Scientific to strengthen end-to-end cold chain logistics services for biopharma customers in the United States. The collaboration enhances temperature-controlled storage and transport capabilities, addressing increasing demand for specialized logistics supporting sample integrity and biopreservation workflows. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Biopreservation Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Biopreservation Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of biopreservation?
What are the growth projections for the biopreservation industry?
How is expanding cell and gene therapy activity influencing demand in the biopreservation market?
What role is AI and automation playing in improving biopreservation practices?
Why is equipment the largest product segment in the biopreservation market?
Why is regenerative medicine the fastest-growing application in the biopreservation market?
Why is North America the leading region in the biopreservation market?
What factors are accelerating biopreservation market growth in Asia Pacific?
Which companies dominate the biopreservation landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization